We are your premier CDMO partner from therapeutic development to GMP cell and lentiviral vector manufacturing. We provide completely integrated solutions carefully engineered for unique cell therapies with gene therapy workflows. We deliver a seamless clinical experience with exclusive access to our cutting-edge technologies and resources for investigational new drug (IND) clearance.
One of the biggest challenges in the cell and gene therapy field is finding the safest and most unobstructed path from pre-IND activities to commercialization. Overcoming the high-risk gaps caused by unknowns related to process and platform, the market, and an evolving regulatory landscape is key for success.
Focusing on clinical and commercial readiness, our team of process and analytical experts leverages the power and capabilities of the latest Miltenyi Biotec technology. We have decades of experience in lentiviral vector design, process development, GMP manufacturing and a broad range of clinically relevant applications in cell processing. We provide customized solutions that will successfully speed you through IND submissions. Together, we build tailored, lasting, turnkey solutions to strengthen clinical programs en route to advanced therapy success.
Our services are based on our own innovative Miltenyi Biotec products, years of experience, and our enthusiasm for developing the perfect cell product together with our customers. We are by your side from pre-clinical to commercial launch and facilitate a smooth ride through all phases of your clinical journey.
We provide high-quality lentiviral vector manufacturing services for the entire research and development cycle. Our state-of-the-art lentiviral vector backbone construct and platform process allows for rapid evaluation, development and scale-up and has been successfully leveraged in numerous clinical trials. We provide extensive process knowledge and a proven, customizable, and commercially viable vector system that’s designed to enhance clinical translation and further standardize the manufacture of unique cell therapies.
We aim to make sure that each technical gap is bridged to simplify your clinical journey. In addition to our cell and lentiviral vector services, we offer full support across our development and manufacturing sites and outside organizations. We prioritize the engineering and seamless continuation of successful manufacturing processes with our network and our technology. We also provide phase-appropriate, regional regulatory support by leveraging our years of experience working in conjunction with different regulatory bodies worldwide.
For more than 30 years, Miltenyi Biotec has played an important role in the advancement of biomedical research and enablement of cell and gene therapy. Today, we are known worldwide for our unparalleled commitment to innovation and technical excellence. We rely on our own time-tested technologies and resources to develop, optimize, and engineer robust GMP-compliant cell manufacturing processes that are specifically tailored to our customers’ cell therapy needs.
To date, we have served as a trusted partner for many cell manufacturing companies in all phases of clinical progression – from small preclinical testing and scale-up, to commercial-scale operations. We have developed products and services that have been used to treat more than 50,000 patients.
For high quality GMP-compliant cell processing we count on our own instruments, disposables and MACS® GMP Products. Our products are developed and optimized for use in clinical cell manufacturing and for many years provided excellent cell products to the field. With our holistic approach we cover a broad range of times tested cell manufacturing applications and are experts in streamlining customized clinical workflows and IPC/QC testing.
The CliniMACS Prodigy Platform is the centerpiece of our idea of GMP-compliant cell production and genetic engineering. It allows for automated end-to-end closed system processes, fully customizable and easy to up-scale. The platform integrates all process steps including cell washing, selection, activation, transduction, and harvest. With additional modules like the CliniMACS Electroporator, automated transfection expands cell engineering possibilities. The CliniMACS Formulation Unit guarantees safe final formulation and filling. In addition to our instruments and expertise, we provide all reagents, buffers, and media. This single-source model helps to reduce regulatory complexities.
Flow cytometry is the most widely used modality in cell therapy, employed to determine incoming product phenotype and composition for in-process control, as well as to evaluate cellular identity and purity of final drug products for release testing. Our MACSQuant Flow Cytometer Platform is the perfect combination to be used in cell manufacturing with tailored analytical tools such as automated calibration, compensation, staining, and harmonized instrument settings across multiple devices and sites.
The customizable Express Mode software on our MACSQuant Analyzers allows fully automated sample acquisition, data analysis, and reporting. Our platform offers a streamlined development paradigm, and ultimately, a faster path to commercialization.
The CliniMACS Cell Factory capitalizes on the automated, closed system cell processing of the CliniMACS Prodigy Platform to reduce cleanroom requirements and enables parallel manufacturing of clinical cell products on multiple instruments – in one room.
No matter if small-scale or large-scale manufacturing is in focus, our standards can be tailored to any vision. All our cell manufacturing locations are built and equipped on the same principle. Our uniform facility design is the basis for consistent manufacturing and analytical processes worldwide. Furthermore, it clearly decreases the challenges that come with process up- and out-scaling. As we solely rely on our own high quality ancillary materials, we are independent of external supply chains and product variations. This lowers regulatory hurdles and accelerates process development.
The CliniMACS Cell Factory brings clinical-scale cell manufacturing to the next level. Our scalable, automated and closed system cell processing platform reduces cleanroom requirements and enables parallel manufacturing of patient material on multiple instruments – in one room.
As a truly international company with a global presence and a flexible infrastructure that enables us to accommodate the changing needs of our customers, we can support virtually any type of project you bring us. Our strategically located GMP cell manufacturing facilities in the US, Europe, and Asia, are well situated to support your needs in many regions. Close proximity to key markets guarantees logistical and operational continuity. Ask how our experts can assist your scale-out visions.
Please fill out this form and a representative of Miltenyi Biotec will contact you to complete your request.
We will process your personal data according to our privacy statement.